This registry is a observational, multi-center study designed to collect data and analyze it retrospectively on patients with cardiac amyloidosis who have been evaluated and treated at major amyloid centers across the US and internationally between 1997 and 2025.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Quantify disease severity at diagnosis, progression and survival in patients with cardiac amyloidosis
Timeframe: 1997 - 2025
Quantify incidence of complications from cardiac amyloidosis
Timeframe: 1997 - 2025